海尔生物：累计回购约259万股

Group 1 - Haier Biomedical announced a share buyback of approximately 2.59 million shares, representing 0.8147% of the total share capital of about 318 million shares, with a total expenditure of approximately 84.12 million RMB [1] - The highest and lowest prices for the repurchased shares were 34.69 RMB and 29.86 RMB per share, respectively [1] - For the year 2024, the revenue composition of Haier Biomedical is 99.57% from medical devices and 0.43% from other businesses [1] Group 2 - As of the latest report, Haier Biomedical has a market capitalization of 11.2 billion RMB [2]